INTRODUCTION
Mutations in genes encoding presenilin 1 (PS1) 2 and presenilin 2 (PS2) are causative in the majority of cases of early onset familial Alzheimer's disease (FAD) (Levy-Lahad et al., 1995; Rogaev et al., 1995; Sherrington et al., 1995) . FAD-linked mutant presenilins elevate the levels of highly amyloidogenic ␤-amyloid (A␤) peptides that are generated by proteolytic processing of APP and deposited early in senile plaques found in the brains of aged individuals and patients with AD (Sisodia et al., 1999) . Recent genetic and biochemical evidence closely links PS1 and PS2 to a protease activity, termed ␥-secretase, which generates the COOH-terminus of A␤ (De Strooper et al., 1998; Naruse et al., 1998; Wolfe et al., 1999) . PS1-mediated cleavage occurs within the transmembrane domain of APP and other membrane proteins such as APP homo- 2 Abbreviations used: Bgt, ␣-Bungarotoxin; AChR, nicotinic acetylcholine receptor; AD, Alzheimer's disease; APP, amyloid precursor protein; A␤, ␤-amyloid peptide; CTF, COOH-terminal fragment; ⌬M1,2, PS1 deletion mutant lacking residues 82-154; ELISA, enzymelinked immunosorbent assay; ER, endoplasmic reticulum; FAD, familial early onset AD; NTF, NH 2 -terminal fragment; PS, presenilin; PS1, presenilin 1; PS2, presenilin 2; TM, transmembrane; wt, wild-type. 64 -82 (2002) doi:10.1006/nbdi.2002.0546 0969-9961/02 $35.00
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